CODEXIS, INC. (CDXS) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-02-09

Key Insights

Alison Moore, the President and CEO of Codexis, Inc. (CDXS), sold 3,826 shares of common stock on February 6, 2026 to satisfy tax or other government withholding obligations in connection with the vesting of her restricted stock units (RSUs).
After the sale, Moore continues to hold 250,506 shares of Codexis common stock, including 136,249 RSUs, indicating she retains a significant stake in the company.
The sale price of $1.3071 per share suggests the transaction was conducted at or near the market price at the time, rather than a large insider sell-off.

Want the newest filings?

This analysis covers the filing from 2026-02-09. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-02-09

Insider Georgia Erbez, the Chief Financial Officer and Chief Business Officer, sold 3,826 shares of Codexis Inc (CDXS) at an average price of $1.3071, likely to satisfy tax or other government withholding obligations related to the vesting of restricted stock units.
Erbez continues to hold 66,810 shares, including 24,374 restricted stock units, suggesting ongoing commitment to the company.
The sale represents a small portion of Erbez's total holdings and may not indicate a significant change in her long-term outlook for the company.

Filed: 2026-02-09

The Chief Scientific Officer of Codexis, Inc. sold 2,492 shares of the company's common stock at $1.3071 per share, likely to satisfy tax or other government withholding obligations.
The reporting person still holds 136,283 shares of Codexis, Inc. common stock, including 35,799 restricted stock units.
The transaction appears to be a routine sale of shares to cover tax obligations and not an indication of a significant change in the insider's position or confidence in the company.

Filed: 2026-01-08

The reporting person, Stefan Lutz, who is the Chief Scientific Officer (CSO) of Codexis, Inc., sold 4,685 shares of the company's common stock at an average price of $1.6968 per share.
The sale was made to cover tax liability incurred due to the vesting and release of Restricted Stock Units held by the reporting person, indicating the transaction was a routine stock sale for tax purposes.
The reporting person still holds 138,775 shares of Codexis common stock, including 41,633 restricted stock units, suggesting they maintain a significant ownership stake in the company.

Other reports for CODEXIS, INC.

Current Report Quarterly Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.